NORAD and breast carcinoma: The increment of miR-155-5p levels was observed in breast cancer cell lines, and targeting of mir-155-5p by NORAD positively regulated the tumour suppressor protein SOCS1, showing ameliorative effects in vitro (Liu W. et al., 2021).